ABNORMAL COAGULATION IN THE POSTOPERATIVE PERIOD CONTRIBUTING TO EXCESSIVE BLEEDING
- 1 September 2001
- journal article
- case report
- Published by Elsevier in Medical Clinics of North America
- Vol. 85 (5) , 1277-1310
- https://doi.org/10.1016/s0025-7125(05)70378-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- ArgatrobanDrugs, 2001
- Cleavage of the antithrombin III binding site in heparin by heparinases and its implication in the generation of low molecular weight heparinProceedings of the National Academy of Sciences, 2000
- Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockadeAmerican Heart Journal, 2000
- Thrombotic Thrombocytopenic Purpura Associated with ClopidogrelNew England Journal of Medicine, 2000
- Bleeding complications with glycoprotein IIb/IIIa inhibitorsDrugs of Today, 2000
- Uremic Bleeding: Closing the Circle After 30 Years of Controversies?Blood, 1999
- Normal Life Expectancy and Thrombosis-Free Survival in Aspirin Treated Essential ThrombocythemiaClinical and Applied Thrombosis/hemostasis, 1999
- Effect of SR121566A, a Potent GP IIb-IIIa Antagonist, on the HIT Serum/heparin-Induced Platelet Mediated Activation of Human Endothelial CellsThrombosis and Haemostasis, 1998
- Heparinase I (Neutralase) Reversal of Systemic AnticoagulationAnesthesiology, 1996
- Pathogenesis of disseminated intravascular coagulation in sepsisPublished by American Medical Association (AMA) ,1993